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Abstract: Development of dual-mode or multi-mode imaging contrast agents is important 
for accurate and self-confirmatory diagnosis of cancer. We report a new multifunctional, 
dendrimer-based gold nanoparticle (AuNP) as a dual-modality contrast agent for magnetic 
resonance (MR)/computed tomography (CT) imaging of breast cancer cells in vitro and in 
vivo. In this study, amine-terminated generation 5 poly(amidoamine) dendrimers modified with 
gadolinium chelate (DOTA-NHS) and polyethylene glycol monomethyl ether were used as 
templates to synthesize AuNPs, followed by Gd(III) chelation and acetylation of the remain-
ing dendrimer terminal amine groups; multifunctional dendrimer-entrapped AuNPs (Gd-Au 
DENPs) were formed. The formed Gd-Au DENPs were used for both in vitro and in vivo 
MR/CT imaging of human MCF-7 cancer cells. Both MR and CT images demonstrate that 
MCF-7 cells and the xenograft tumor model can be effectively imaged. The Gd-Au DENPs 
uptake, mainly in the cell cytoplasm, was confirmed by transmission electron microscopy. 
The cell cytotoxicity assay, cell morphology observation, and flow cytometry show that the 
developed Gd-Au DENPs have good biocompatibility in the given concentration range. Our 
results clearly suggest that the synthetic Gd-Au DENPs are amenable for dual-modality MR/CT 
imaging of breast cancer cells.
Keywords: PAMAM dendrimers, gold nanoparticles, gadolinium, PEGylation, CT imaging, 
MR imaging, breast cancer cells
Introduction
Over the past decade, molecular imaging (MI) has provided the possibility of obtaining 
in vitro and in vivo physiological and pathological information with high sensitivity 
and specificity.1 The modalities of MI include optical imaging,2 computed tomography 
(CT) imaging,3 magnetic resonance (MR) imaging,4 position emission tomography,5 
and single photon emission computed tomography.6 As two of the important MI 
technologies, CT and MR afford better resolution than other imaging modalities. They 
will have more advantages when appropriate MI probes are used.
Recent advances in nanotechnology show that multifunctional nanomaterials can 
be used as MI probes, which are able to not only carry targeting molecules and drugs 
to perform targeted diagnosis and therapeutics,7 but also afford different imaging 
modalities dependent on the composition of the materials.8 For accurate and self-
confirming cancer diagnosis, it is essential to combine dual-mode and multi-mode 
imaging functionalities within one nanoparticle (NP) system, which can avoid putting 
additional stress on the body’s blood clearance capability via administration of multiple 
doses of agents.8
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Due to the limitations of the clinically used CT contrast 
agents, such as short imaging time, renal toxicity at relatively 
high concentrations, and nonspecificity, NP-based inorganic 
agents have been developed. For example, gold NPs 
(AuNPs)3,9 with a high X-ray absorption coefficient, have 
been used as CT contrast agents due to their satisfactory 
biocompatibility after surface functionalization, long blood 
circulation time, and easy biofunctionalization on the surface. 
On the other hand, gadolinium (Gd)-based T1 contrast agents, 
which are now widely used as MR contrast agents for clinical 
diagnosis, also have some shortcomings, such as low T1 
relaxivity, short blood half-life, and the instability of Gd(III)/
diethylenetriaminepentaacetic acid (DTPA) complexes that 
can cause nephrogenic systemic fibrosis.10,11 Consequently, 
macromolecular MR contrast agents have been developed. 
These macromolecular agents have promising features, 
such as well-defined structure, desirable pharmacokinetics, 
and high in vivo T1 relaxivity.12,13 However, very few 
contrast agents have been developed that provide multiple 
imaging contrast effects (ie, effective for both MR and 
CT imaging). These multimodal imaging probes, such as 
iohexol-gadoteridol,14 Gd-G8 dendrimer,15 Gd-chelated 
AuNPs,16,17 and FePt NPs,18 have offered somewhat limited 
sensitivity, stability, or blood circulation time. Therefore, the 
preparation of a dual-modality contrast agent that is stable 
while permitting sensitive imaging with both MR and CT 
still remains a great challenge.
The surface of the poly(amidoamine) (PAMAM) 
dendrimers can be modified with different peripheral 
functional groups that allow them to be used in various 
biomedical applications, such as conjugating chelating agents 
for MR contrast agents19 or for the delivery of drugs and 
nucleic acids.20,21 Additionally, the interior features of the 
dendrimers enable them to be used as templates or stabilizers 
for preparation of inorganic NPs,22 such as gold and silver. 
Our previous studies3,23–25 have shown that the generation 5 
(G5) PAMAM dendrimer-entrapped gold nanoparticles (Au 
DENPs) can be used as blood pool CT contrast agents or 
targeted cancer-specific CT agents. In a very recent study,26 
we have shown that Gd-loaded Au DENPs (Gd-Au DENPs) 
prepared using the facile dendrimer chemistry enable MR/CT 
dual-mode imaging of the heart, liver, kidney, and bladder 
of rat or mouse within a time frame of 45 minutes. Our 
prior successes lead us to hypothesize that the synthesized 
multifunctional Gd-Au DENPs may also be used for dual-
mode MR/CT imaging of tumors.
In this study, following the protocols reported in our 
previous work,26 multifunctional Gd-Au DENPs were 
synthesized and characterized for dual-mode MR/CT imaging 
of breast cancer cells in vitro and in vivo. The cytotoxicity 
of the multifunctional Gd-Au DENPs was evaluated via 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) cell viability assay and flow cytometry. The 
cellular particles taken up were confirmed via transmission 
electron microscopy (TEM) imaging. Finally, the Gd-Au 
DENPs were used for dual-mode MR/CT imaging of 
MCF-7 cells in vitro and xenografted tumor model in vivo. 
Materials and methods
Characterization techniques
The multifunctional Au-DENPs were synthesized and 
characterized according to our previous protocol.26 A Lambda 
25 UV/Vis spectrometer (PerkinElmer, Waltham, MA, 
USA) was used to collect ultraviolet and visible (UV-Vis) 
spectra. A JEOL 2010F analytical electron microscope 
(JEOL, Tokyo, Japan) was used to characterize the size and 
morphology of the Gd-Au DENPs.
Cell culture
MCF-7 breast cancer cells were continuously cultured in 
RPMI 1640 medium with 10% Fetal Bovine Serum (FBS) 
at 37°C and 5% CO2.
Cytotoxicity of Gd-Au DENPs
The cytotoxicity of Gd-Au DENPs was conducted according 
to a previously reported method.23,27 The morphology of the 
cells after treatment with the Gd-Au DENPs was observed 
with optical microscopy (Nikon, Tokyo, Japan) after 
staining with hematoxylin and eosin (HE). The viability of 
cells treated with the Gd-Au DENPs was evaluated using 
an MTT assay. Varying concentrations of Gd-Au DENPs 
([Au] = 5–50 μM) was added into the MCF-7 cell culturing 
medium. The toxicity of the Gd-Au DENPs was further 
examined by the flow cytometric detection of cell cycles and 
apoptosis. MCF-7 cells were cultured with fresh medium 
containing different concentrations of the Gd-Au DENPs 
([Au] = 25 and 50 μM).
Cellular uptake of the Gd-Au DENPs
Cellular uptake of the Gd-Au DENPs was observed by 
using an H600 transmission electron microscope (TEM), 
(Hitachi, Tokyo, Japan) operating at a voltage of 60 kV. 
MCF-7 cells were plated in 6-well cell culture plates at a 
density of 3 × 105 cells per well in RPMI 1640 medium 
with 10% FBS for 24 hours to grow to approximately 80% 
confluence. Then the Gd-Au DENPs were added to each 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2590
Li et alInternational Journal of Nanomedicine 2013:8
well with a final Au concentration of 50 μM and incubated 
for 24 hours at 37°C.
In vitro MR/CT imaging of breast 
cancer cells
For dual-mode MR/CT imaging, MCF-7 cells were 
incubated with Gd-Au DENPs at different Au concentrations 
(0–50 μM) for 4 hours at 37°C. After washing three times 
with phosphate buffered saline (PBS), the cells were 
trypsinized, centrifuged, and resuspended with 100 μL of PBS 
in a 0.5 mL Eppendorf tube (Eppendorf, Hamburg, Germany) 
that contained approximately 1.5 × 106 cells in each tube. The 
T1 relaxation rate for each sample was measured using a 3.0 
T Signa HDxt superconducting MR system (GE Medical 
Systems, Milwaukee, WI, USA) with a wrist receiver coil 
and a fast spin-echo sequence (repetition time [TR]/echo 
time [TE] = 2000/81.9 ms, matrix = 256 × 256, section 
thickness = 2 mm, and field of view [FOV] = 80 × 80 mm). 
Regions of interest were selected to encompass cross-
sections of respective tubes. The mean T1 weighted signal 
intensity was measured for each cell sample (Smean). Separate 
regions of interest were drawn outside the tube to estimate 
relative noise levels based upon the standard deviation of the 
background signal (NSD). Then the relative signal-to-noise 
ratio (SNR = Smean/NSD) were calculated. For tumor-bearing 
mice (see below), these SNR measurements were repeated 
for each MR scan before or after injection.
For CT imaging, the cell suspension in each tube was 
placed in a self-designed scanning holder and then scanned 
using a volume computed tomography (VCT) imaging system 
(GE LightSpeed, GE Medical Systems, Milwaukee, WI, USA), 
operating at 80 mA, 100 kV with 0.625-mm thickness.
In vivo MR/CT imaging
Animal experiments and animal care were conducted 
according to protocols approved by the institutional committee. 
Male 4-week-old BALB/c nude mice (n=9, Slac Laboratory 
Animal Center, Shanghai, People’s Republic of China) were 
subcutaneously injected with 1 × 106 cells/mouse in the right 
second mammary fat pad. When the tumor nodules reached a 
volume of 0.1–1 cm3, approximately 3 weeks after injection, 
the mice were anesthetized with an intraperitoneal injection of 
0.3 mL of 3% pentobarbital sodium (12 mL/kg), and 200 μL 
of Gd-Au DENPs ([Au] = 50 mM, [Gd] = 5.34 mM) was 
delivered via the tail vein. MR scans were performed before 
injection and 30 minutes, 120 minutes, 180 minutes, 12 hours 
and 24 hours after injection of the particles. A 3.0 T Signa 
HDxt superconducting clinical MR system (GE Medical 
Systems) was used with a custom-built rodent receiver coil 
(Chenguang Med Tech, Shanghai, People’s Republic of 
China). At each time point for each animal, 2D spin-echo MR 
images were obtained with a 2-mm slice thickness, TR/TE 
2000/81.9 ms, a 6 × 6 cm FOV , and a 256 × 160 matrix. The 
MR images were processed using the strategy described above 
for in vitro MR studies.
For CT imaging of the tumor model, the scans were 
performed before and 15 minutes, 100 minutes, 160 minutes, 
12 hours, and 24 hours after injection of the particles using a 
GE LightSpeed VCT clinical imaging system (GE Medical 
Systems) with a 100 kV tube voltage, an electrical current 
of 80 mA, and a slice thickness of 0.625 mm.
In vivo biodistribution of Gd-Au DENPs
After MR and CT imaging of the tumor model at the 
different time points after injection of the Gd-Au DENPs 
([Au] = 50 mM), the mice were euthanized. The liver, spleen, 
heart, blood, kidney, and tumors of the mice were extracted 
and weighed. The organs were cut into small pieces and 
incubated in aqua regia solution overnight. The Au content 
was determined using a Leeman Prodigy inductively coupled 
plasma atomic emission spectroscopy (ICP-AES, Teledyne 
Leeman Labs, Hudson, NH, USA).
Statistical analysis
The significance of the experimental data were evaluated 
by one-way ANOVA statistical analysis. The significance 
level was set as 0.05.
Results and discussion
Synthesis and characterization 
of Gd-Au DENPs
Similar to our previous study,26 amine-terminated G5 
PAMAM dendrimers were multifunctionalized through 
grafting gadolinium chelator DOTA-NHS and carboxylic 
acid functionalized methoxyl polyethylene glycol onto their 
surface. Using functional G5 dendrimers as templates, Au 
DENPs were prepared with sodium borohydride reduction 
chemistry. After chelating Gd(III) ions with the attached 
DOTA moieties onto the dendrimer surface, the remaining 
dendrimer terminal amine groups were acetylated to neutralize 
the positive charges. The obtained multifunctional Gd-Au 
DENPs were used for both MR and CT imaging of cancer 
cells in this study. Detailed characterization of the Gd-Au 
DENPs can be seen in our previous study26 and in the 
supporting information. Figure 1 shows the UV-Vis spectrum 
of the Gd-Au DENPs. The surface plasma resonance peak 
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located at 520 nm clearly indicates the formation of AuNPs. 
In addition, the size and morphology of the Gd-Au DENPs 
were characterized with TEM (Figure 2). It can be seen that 
the Gd-Au DENPs have a spherical shape and a uniform 
size distribution. The diameter of the Gd-Au DENPs was 
estimated to be 4.3 nm. Similar to our previous study,26 with 
the coexistence of two radiodense imaging elements of Gd(III) 
ions and AuNPs within one NP system, the formed Gd-Au 
DENPs display both T1 relaxivity (for T1 MR imaging mode) 
and X-ray attenuation property (for CT imaging mode), which 
enables MR/CT dual-mode imaging applications.
Cytotoxicity of Gd-Au DENPs
Before using the Gd-Au DENPs for MR and CT dual-
modality molecular imaging of the model breast cancer 
cell line, their cytocompatibility was explored. In general, the 
cytotoxicity of amine-terminated G5 PAMAM dendrimers 
arises from the strong electrostatic interaction between the 
positively charged dendrimers and the negatively charged cell 
membranes.28 Therefore, it is crucial to neutralize the positive 
charges of the formed Gd-Au DENPs via a final acetylation 
step. MCF-7 cells were used to test the cytotoxicity of the 
Gd-Au DENPs by MTT cell viability assay, cell morphology 
observation, and flow cytometric analysis of the cell cycles 
and apoptosis.
MTT assay was performed to evaluate the cell viability 
by incubation of the MCF-7 cells with Gd-Au DENPs at 0, 
5, 10, 25, and 50 μM concentrations for 24 hours (Figure 3). 
The viability of the cells treated with Gd-Au DENPs did not 
exhibit any significant differences compared with the cells 
treated with PBS buffer (P . 0.05). The nontoxicity of the 
Gd-Au DENPs at 50 μM concentration may be due to the 
acetylation and PEGylation modification of the dendrimer 
surface. This is very important for their biomedical imaging 
applications, particularly under circumstances that require 
the particle concentration to be sufficiently high for in vivo 
detection.
The morphology of the HE-stained MCF-7 cells before and 
after incubation with the Gd-Au DENPs was observed using 
optical microscopy (Figure 4). It is clear that morphology of 
the cells incubated with different concentrations of Gd-Au 
DENPs did not display any apparent changes compared to the 
control cells treated with PBS buffer. These results indicate 
that the Gd-Au DENPs did not impact of the morphology 
of the MCF-7 cells, in agreement with our previous report 
related to PEGylated Au DENPs.23
Flow cytometry was used to further investigate the 
influence of the Gd-Au DENPs on the cell cycle and 
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Figure 1 UV-Vis spectrum of Gd-Au DENPs.
Abbreviations:  Gd-Au  DENP,  dendrimer-entrapped  gold  nanoparticle; 
UV-Vis, ultraviolet and visible spectrum.
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Figure 2 TEM image and size distribution histogram of Gd-Au DENPs.
Abbreviations: Gd-Au DENP, dendrimer-entrapped gold nanoparticle; TEM, transmission electron microscopy.
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apoptosis (Table 1 and Figure S3). The sub-G1 fraction of 
the MCF-7 cells incubated with the Gd-Au DENPs at Au 
concentrations of 25 μM and 50 μM were determined to 
be 2.39 ± 0.25% and 2.46 ± 0.47%, respectively. Compared 
with the negative control cells treated with PBS buffer 
(2.24 ± 0.12%), there was no statistical difference. This result 
demonstrates that the Gd-Au DENPs have no effect on the 
cell cycle of the MCF-7 cells.
In brief, the combined MTT assay of cell viability, the 
observation of cell morphology, and the flow cytometric 
analysis of the cell cycles and apoptosis clearly indicate 
that the Gd-Au DENPs are noncytotoxic in the given 
concentration range, which is essential for their MR/CT 
dual-modality imaging applications.
In vitro cellular uptake of Gd-Au DENPs
For efficient imaging of cancer cells, it is important to 
explore the ability of the particles to be taken up by the 
cells. MCF-7 cells treated with the Gd-Au DENPs were 
examined using TEM to identify the distribution of the 
particles in the subcellular compartments. In the TEM images 
(Figure 5), numerous high electron-staining particles can be 
observed in the cytoplasm of the MCF-7 cells, particularly 
in the lysosomes of the cell after incubation with the Gd-Au 
DENPs for 24 hours. This result confirmed that the Gd-Au 
DENPs were internalized by the cell rather than adhering 
to the surface of the cells. The internalization of the Gd-Au 
DENPs potentially occurs through two distinct mechanisms, 
phagocytosis and diffusion via cell walls, in agreement 
with the literature.29,30 Furthermore, the TEM data also 
revealed that the incubation of the Gd-Au DENPs with an 
Au concentration as high as 50 μM did not markedly affect 
the cell morphology, corroborating with the MTT assay and 
optical microscopy observation data.
MR/CT dual-modality imaging of breast 
cancer cells in vitro
To prove our hypothesis that the developed Gd-Au DENPs 
are able to be used as MR/CT dual-modality contrast 
agents for cancer cell imaging, the suspensions of MCF-7 
cells incubated with Gd-Au DENPs at different Au 
concentrations (0 μM, 5 μM, 10 μM, 25 μM, and 50 μM, 
respectively) were imaged using clinical MR and CT 
imaging systems. Figures 6 and 7 present transverse MR 
images and the sagittal CT images of MCF-7 cells with or 
without incubation with the Gd-Au DENPs. MCF-7 cell 
suspensions incubated with increasing concentrations of 
Gd-Au DENPs displayed increased contrast enhancement 
when compared to control cells treated with PBS buffer. Both 
the T1-weighted MR images (Figure 6A) and the CT images 
(Figure 7A) of cells incubated with Gd-Au DENPs at high 
Au concentrations (25 μM and 50 μM) were much brighter 
than those of the cells incubated with Gd-Au DENPs at low 
concentrations (5 μM and 10 μM) and those of the negative 
control cells treated with PBS buffer.
A quantitative analysis of the MR images (Figure 6B) 
further revealed that the T1-weighted SNR of MCF-7 cells 
incubated with the Gd-Au DENPs at the Au concentration 
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Figure 3 MTT assay of MCF-7 cell viability after treatment with Gd-Au DENPs at 
the gold concentration of 0–50 μM for 24 hours.
Note: MCF-7 cells treated with PBS buffer were used as a control.
Abbreviations: Au, gold; Gd-Au DENP, dendrimer-entrapped gold nanoparticle; 
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PBS, phosphate 
buffered saline.
Figure 4 The morphology of MCF-7 cells treated with PBS buffer (A) and Gd-Au DENPs at the Au concentrations of 25 μM (B) and 50 μM (C) for 24 hours.
Abbreviations: Au, gold; Gd-Au DENP, dendrimer-entrapped gold nanoparticle; PBS, phosphate buffered saline.
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Table 1 Apoptosis and cell cycle analysis of MCF-7 cells after incubation with the Gd-Au DENPs for 4 hours (mean ± SD, n=4)
Group Apoptosis (%) Cell cycle (%)
G0–G1 G2-M S G2/G1
Control 2.24 ± 0.12 51.73 ± 0.32 1.33 ± 0.06 47.15 ± 0.32 2.13 ± 0.01
25 μM (Au) 2.39 ± 0.25 51.94 ± 0.58 1.58 ± 0.15 46.46 ± 0.48 2.24 ± 0.02
50 μM (Au) 2.46 ± 0.47 51.29 ± 0.56 1.28 ± 0.19 47.62 ± 0.49 2.16 ± 0.01
Abbreviations: Au, gold; G, gap; Gd-Au DENP, dendrimer-entrapped gold nanoparticle; M, metaphase; S, synthesis; SD, standard deviation.
AB
1 µm1  µm
Figure 5 TEM images of the MCF-7 cells incubated with Gd-Au DENPs at a concentration of 50 μM for 24 hours (A) and the negative control cells without treatment (B).
Notes: Gd-Au DENPs were taken up by endosomes as electron-dense nanoparticles, indicated by black arrows; the white arrows show the normal endosome without 
Gd-Au DENPs.
Abbreviations: Gd-Au DENP, dendrimer-entrapped gold nanoparticle; TEM, transmission electron microscopy.
of 50 μM was significantly greater than those of the cells 
incubated with Gd-Au DENPs at lower concentrations (5 μM, 
10 μM, and 25 μM, respectively) and that of the negative 
control cells (P,0.05). Likewise, a quantitative analysis of 
the CT values of these cell samples (Figure 7B) revealed the 
same trend of increased CT value with the Au concentration 
of the particles. The brighter MR and CT images (higher T1 
SNR and CT values) of cell samples should be associated 
with greater cellular uptake of the particles at a higher 
concentration of Gd-Au DENPs. Overall, the in vitro cell 
imaging experiments demonstrate that the Gd-Au DENPs 
are able to be used as a positive contrast agent for both MR 
and CT imaging of cancer cells.
MR/CT dual-modality imaging of MCF-7 
xenograft tumor model
The excellent in vitro MR/CT imaging performance of the 
Gd-Au DENPs along with the good biocompatibility of the 
NPs motivated us to pursue their applicability for in vivo 
MR/CT imaging of the xenotransplanted tumor model. For 
MR imaging, MCF-7 tumor-bearing BALB/c nude mice 
were administered 200 μL Gd-Au DENPs ([Gd] = 5.34 mM, 
[Au] = 50 mM) via the tail vein. MR images (Figure 8A) 
were obtained both before administration and 30 minutes, 
120 minutes, 180 minutes, 12 hours, and 24 hours after 
administration of the Gd-Au DENPs using a clinically 
relevant field strength of 3 tesla (T) MR system. It is clear 
that the tumor site exhibits an obvious enhancement with a 
significantly higher T1-weighted SNR after administration 
of the Gd-Au DENPs compared with those before injection. 
Quantitative analysis of the MR T1-weighted SNR values 
of the tumor area at different time points revealed that the 
tumor area had a higher SNR value at 120 minutes after 
injection. At the time point of 24 hours after injection, 
the T1-weighted SNR value of the tumor area was still 
much higher than that of the tumor area before injection 
(Figure 8B).
For CT imaging, after the same dose of Gd-Au DENPs 
was intravenously injected via the tail vein, CT scans were 
performed at 15 minutes, 100 minutes, 160 minutes, 12 hours, 
and 24 hours after injection using a clinical CT imaging 
system. Figure 9 shows the tumor CT images before and 
after injection of the Gd-Au DENPs. The tumor site has 
obvious enhancement, with significantly brighter images, 
after administration of the Gd-Au DENPs compared with 
the images before the injection (Figure 9A). Quantitative 
analysis of the CT value of the tumor area at different time 
points showed that the tumor area had the highest CT value 
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Figure 6 Transverse MR images (A) and MR SNR values (B) of the MCF-7 cells 
treated with Gd-Au DENPs at different concentrations for 4 hours (n=3).
Abbreviations: Au, gold; Gd-Au DENP, dendrimer-entrapped gold nanoparticle; 
MR, magnetic resonance; SNR, signal-to-noise ratio.
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Figure 7 Sagittal CT images (A) and CT values (B) of the MCF-7 cells treated with 
Gd-Au DENPs at different concentrations for 4 hours (n=3).
Abbreviations: Au, gold; CT, computed tomography; Gd-Au DENP, dendrimer-
entrapped gold nanoparticle; SNR, signal-to-noise ratio.
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Figure 8 Representative transverse MR images (A) and MR SNR values (B) of the 
MCF-7 tumor xenografts in nude mice before and after intravenous injection with 
Gd-Au DENPs for 30 minutes, 120 minutes, 180 minutes, 12 hours, and 24 hours, 
respectively.
Note: The white arrows in (A) indicate the location of the tumor.
Abbreviations: Gd-Au DENP, dendrimer-entrapped gold nanoparticle; h, hours; 
min, minutes; MR, magnetic resonance; SNR, signal-to-noise ratio.
at 100 minutes after injection, and at 24 hours after injection, 
the CT value of the tumor area was still much higher than 
it was before injection (Figure 9B). The CT imaging results 
are in accordance with the MR imaging data, although the 
imaging time points are not exactly the same.
The efficient MR/CT imaging of the MCF-7 tumor model 
suggests that the developed Gd-Au DENPs demonstrate 
prolonged blood circulation time, which may be partly 
due to the modification of PEG moieties on the surface of 
dendrimers, similar to our previous study.23 With the prolonged 
blood circulation time, part of the Gd-Au DENPs could be 
transported to the tumor site via the enhanced permeability 
and retention (EPR) effect,31–34 thereby allowing for effective 
MR/CT imaging of tumors. This is very important for the early 
stage diagnosis of unknown tumors. Our results confirm that the 
developed Gd-Au DENPs can be used as a dual-mode contrast 
agent for MR/CT imaging of tumors in vivo. In addition, the 
xenografted MCF-7 tumors were confirmed by gross specimen 
(Figure S4A and B) and HE staining (Figure S4C), which 
showed the features of the MCF-7 cells.
In vivo biodistribution of Gd-Au DENPs
The tumor uptake and the biodistribution of the Gd-Au 
DENPs were investigated at 1 hour, 4 hours, 12 hours, and 
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1 hour after intravenous injection, which enabled effective 
MR/CT imaging of the tumors. The biodistribution of 
the Gd-Au DENPs in blood further confirmed their long 
blood circulation time. At 1 hour after injection, the 
biodistribution of the NPs in blood was measured to be 
0.0124 g/kg ± 0.008 g/kg, and the particle concentration was 
estimated to be 0.0080 g/kg ± 0.0008 g/kg at 24 hours after 
administration. The prolonged blood circulation time is likely 
due to the modification of PEG moieties on the dendrimer 
surface, effectively avoiding the nonspecific uptake by the 
reticuloenthelial system.35 Detailed pharmacokinetic studies 
of the Gd-Au DENPs at extended time periods are still 
necessary for a thorough understanding of the biodistribution 
of the NPs.
Conclusion
Multifunctional Gd(III)-loaded Au DENPs were effectively 
used as a dual-modality contrast agent for MR/CT 
molecular imaging of breast cancer cells in vitro and 
in vivo. MTT assay of cell viability, cell morphology 
observation, and the flow cytometry analysis of the cell 
cycles and apoptosis reveal that the Gd-Au DENPs are 
noncytotoxic in a concentration range of 0–50 μM. The 
efficient cellular uptake of the Gd-Au DENPs as verified 
by TEM enables dual-mode MR/CT imaging of breast 
cancer cells (MCF-7 cells) in vitro after incubation of 
the particles and the xenograft tumor model in vivo after 
intravenous injection of the particles. The developed 
Gd-Au DENPs are expected to be used as a multifunctional 
nanoplatform for MR/CT molecular imaging of different 
types of cancer.
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Figure 10 The biodistribution of Gd-Au DENPs in different organs and the MCF-7 
tumor xenograft.
Note: The data were obtained by ICP-AES at the indicated time after injection in 
the MCF-7–xenografted BALB/c nude mice models.
Abbreviations: Au, gold; Gd-Au DENP, dendrimer-entrapped gold nanoparticle; h, 
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24 hours after intravenous administration. ICP-AES was 
performed to analyze the Au concentration in the tumor and 
several major organs, including the heart, lung, spleen, liver, 
kidney, and blood (Figure 10). The lung showed the most 
significant Au uptake (0.943 g/kg ± 0.223 g/kg) at the 4-hour 
time point, whereas the spleen showed the most significant Au 
uptake (0.742 g/kg ± 0.198 g/kg) at the 24-hour time point, 
which is similar to results from our previous studies.23,26 These 
results suggest that the multifunctional NPs are able to pass 
the lung first from the inferior vena cava and the right heart, 
and some NPs are most likely held back by the pulmonary 
capillary network. The lower uptake of Au in both the liver 
and kidney suggests that the Gd-Au DENPs are able to 
escape the reticuloenthelial system located in the liver and 
pass through the renal filter, consequently allowing for an 
efficient transport of the particles to the tumor region via the 
passive EPR effect. In this study, the Au uptake in the tumor 
region was measured to be up to 0.276 g/kg ± 0.006 g/kg at 
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Figure S1 Color T1-weighted images (A) and linear fitting of R1 (B) of G5-Gd (1) and Gd-Au DENPs (2) as a function of Gd concentration.
Note: The color bar from red to blue indicates the gradual decrease of the T1 value.
Abbreviations: DENP, dendrimer-entrapped nanoparticle; Gd, gadolinium; Gd-Au DENP, dendrimer-entrapped gold nanoparticle.
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Figure S2 CT phantom images (A) and X-ray attenuation (HU) (B) of Gd-Au DENPs (1) and Au DENPs (2) as a function of gold concentration.
Abbreviations: Au, gold; CT, computed tomography; DENP, dendrimer-entrapped nanoparticle; Gd-Au DENP, dendrimer-entrapped gold nanoparticle; HU, housefield unit.
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Figure S4 MCF-7 xenografted nude mice models (A), resected tumor (B), and optical microscope image of an HE-stained tumor section (C).
Note: The magnification for the tumor section was set at 200×.
Abbreviation: HE, hematoxylin and eosin.
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Figure S3 Flow cytometry analysis of MCF-7 cells treated without (A) or with Gd-Au DENPs at concentrations (Au) of 25 μM (B) and 50 μM (C) for 4 hours (n=4).
Abbreviations: Au, gold; Gd-Au DENP, dendrimer-entrapped gold nanoparticle.
Table S1 MR T1 relaxation rate and X-ray attenuation properties of Gd-Au DENPs
MR T1 relaxation rate and X-ray attenuation properties of Gd-Au DENPs were obtained as previously described.1 MR T1-weighted imaging for G5-Gd 
and Gd-Au DENPs was performed using increasing gadolinium concentrations (Gd; 0.12 mM, 0.24 mM, 0.40 mM, 0.66 mM, 1.02 mM, and 1.28 mM 
for Gd NPs and 0.25 mM, 0.56 mM, 0.83 mM, 1.37 mM, 2.18 mM, and 2.74 mM for the Gd-Au DENPs). Both the G5-Gd and Gd-Au DENPs exerted 
positive contrast effects in a dose-dependent manner, as shown in Figure S1. However, the T1 relaxivities (the slope of the graph of 1/T1) of the 
G5-Gd and Gd-Au DENPs were 4.82 mM−1 s−1 and 1.04 mM−1 s−1, respectively (Figure S1B), which means that the T1 relaxivities of the Gd-Au DENPs 
were reduced compared to the G5-Gd. This result indicated that there is most likely an interaction between the Gd and gold nanoparticles, which 
requires further intensive study.
CT images of phantoms containing Gd-Au DENPs and Au DENPs at various gold concentrations (10 mM, 20 mM, 30 mM, 50 mM, 80 mM, 100 mM) 
revealed that these particles clearly result in X-ray attenuation, even when the gold concentration is only 10 mM (Figure S2). As expected, significant 
dose-dependent inverse CT image contrast was observed in both arrays (Figure S2), which is consistent with our previous report.2 Compared 
with the arrays of Au DENPs, the Gd-Au DENPs exerted a better contrast effect with the same gold concentrations in the experiment, likely the 
existence of Gd3+, which may contribute to a small additional amount of X-ray attenuation within the CT images, although the Gd K-edge energy 
(50.2 KeV) is considerably lower than that of gold (80.7 KeV).3,4
Abbreviations:  Au,  gold;  CT,  computed  tomography;  Gd,  gadolinium;  Gd-Au  DENP,  dendrimer-entrapped  gold  nanoparticle;  Gd3+,  ;  MR,  magnetic  resonance; 
NP, nanoparticle.
Table S2 Histology study
After the final MR and CT scan, each mouse was deeply anesthetized, and the tumor was resected. The tumor tissues were postfixed with 4% 
paraformaldehyde in a 0.1 M phosphate buffer (pH 7.4) for 24 hours, and then dehydrated, embedded, and sectioned into 3 μm-thick slices. After being 
dewaxed and rehydrated, the tumor sections were stained with hematoxylin and eosin.
Abbreviations: CT, computed tomography; MR, magnetic resonance.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2599
Dendrimer-based nanoparticle for dual-mode breast cancer imagingInternational Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2013:8
References
1.  Wen S, Li K, Cai H, et al. Multifunctional dendrimer-entrapped gold 
nanoparticles for dual mode CT/MR imaging applications. Biomaterials. 
2013;34(5):1570–1580.
2.  Shi X, Wang S, Sun H, Baker JR Jr. Improved biocompatibility of surface 
functionalized dendrimer entrapped gold nanoparticles. Soft Matter. 
2007;3:71–74.
3.  Alric C, Taleb J, Le Duc G, et al. Gadolinium chelate coated gold 
nanoparticles as contrast agents for both X-ray computed tomography 
and magnetic resonance imaging. J Am Chem Soc. 2008;130: 
5908–5915.
4.  Md NS, Kim H-K, Park J-A, Chang Y, Kim T-J. Gold nanoparticles 
coated with Gd-chelate as a potential CT/MRI bimodal contrast agent. 
Bull Korean Chem Soc. 2010;31(5):1177–1181.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
2600
Li et al